Chemo-scale™ is a non-invasive therapy guidance solution designed to evaluate how an individual patient’s tumor cells respond to anti-cancer drugs. By directly studying the effect of chemotherapy and re-purposed/ naturopathic drugs on fresh tumor cells or Circulating Tumor-Associated Cells (C-TACs), it enables clinicians to identify the most effective treatment options for each patient. This personalized approach helps reduce the uncertainty of conventional “trial-and-error” treatment selection by providing drug sensitivity and low responsive drug profiles specific to the patient’s cancer biology.
Supporting Smarter, Patient-Specific Therapy Decisions
Identify the most effective chemotherapy options based on the patient’s individual tumor response
Evaluate sensitivity and low responsive drug patterns unique to each patient’s cancer
Directly assess the effect of anti-cancer drugs on live tumor-associated cells
Minimize ineffective therapies, unnecessary toxicity, and treatment delays
Where Tumor Biology Meets Treatment Action
Analyze the response of tumor cells to multiple chemotherapeutic agents individually
Detect low responsive drug patterns that may impact treatment effectiveness
Utilize Circulating Tumor-Associated Cells (C-TACs) from peripheral blood when biopsy tissue is unavailable
Help clinicians select therapies with higher probability of clinical benefit
Real Tumor Behavior. Real Treatment Decisions.
Assess tumor sensitivity before initiating chemotherapy.
Identify drugs with the highest potential effectiveness for the patient.
Detect chemotherapy agents that may be less effective or ineffective.
Support refinement of therapy strategies based on tumor response patterns.
Enable evidence-based treatment decisions tailored to the patient’s tumor biology.
Indication of which anti-cancer drugs may be most effective.
Insights tailored specifically to the patient's cancer.
Direct biological response of tumor-associated cells to tested therapies.
Ranking of cytotoxic drugs in descending order of effectiveness.
Insights into the potential effectiveness of selected re-purposed drugs alongside standard chemotherapy agents.
Cancer is a highly heterogeneous disease, and patients with the same cancer type often respond differently to identical treatment regimens. Conventional treatment approaches may rely on generalized protocols that do not fully account for the unique biology of an individual patient’s tumor. Chemo-scale™ directly evaluates how a patient’s tumor cells respond to anti-cancer drugs in vitro, enabling clinicians to personalize treatment selection. This approach can help reduce ineffective therapies, lower unnecessary toxicity, improve treatment efficiency, and support more informed clinical decisions.
Fresh tumor biopsy tissue or peripheral blood sample collection
Isolation of viable tumor cells or Circulating Tumor-Associated Cells (C-TACs)
Direct ex vivo exposure of tumor-associated cells to a panel of anti-cancer agentss
Quantitative assessment of tumor cell response to individual drugs based on cell death (CD) metrics
Drugs ranked in descending order of cell death (CD) values, enabling clear stratification of sensitivity vs resistance